SCHEMBL21552228

SCHEMBL21552228

CO[C@@H]1[C@H](O)[C@@H](COP(N)O)O[C@H]1n1cc(I)c(N)nc1=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADK P55263 6/20 0.41
LMNA P02545 2/20 0.34
MTOR P42345 2/20 0.34
THRB P10828 1/20 0.34
MDM2 Q00987 1/20 0.34
NCOA1 Q15788 1/20 0.34
NCOA3 Q9Y6Q9 1/20 0.34
GMNN O75496 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TP53 P04637 1/20 0.34
NFKB1 P19838 1/20 0.34
DNMT1 P26358 1/20 0.34
THPO P40225 1/20 0.34
HTT P42858 1/20 0.34
RAB9A P51151 1/20 0.34
BLM P54132 1/20 0.34
HBB P68871 1/20 0.34
PMP22 Q01453 1/20 0.34
ADORA3 P0DMS8 1/20 0.33
RNASEL Q05823 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29495155 0.89 ADK (0.47) ADKLMNAMTORTHRBMDM2
SCHEMBL3740426 0.86 LMNA (0.46) ADKLMNAMTORTHRBMDM2
SCHEMBL17948541 0.86 LMNA (0.46) ADKLMNAMTORTHRBMDM2
SCHEMBL3740421 0.86 LMNA (0.46) ADKLMNAMTORTHRBMDM2
SCHEMBL1683180 0.82 LMNA (0.55) LMNAMTORTHRBMDM2NCOA1
SCHEMBL21551984 0.81 PYGM (0.53) P2RY6
SCHEMBL21552277 0.79 TYMP (0.52) ADK
SCHEMBL21552279 0.79 TYMP (0.52) ADK
SCHEMBL1065626 0.78 LMNA (0.44) ADKLMNAMTORTHRBMDM2
SCHEMBL21999231 0.78 ADK (0.42) ADKLMNAMTORTHRBMDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3983077-A1 DELIVERY OF OLIGONUCLEOTIDES TO THE STRIATUM Alnylam Pharmaceuticals, Inc. (US) 2022-04-20 EP disclosed
EP-3790970-A1 EXTRAHEPATIC DELIVERY Alnylam Pharmaceuticals Inc. (US) 2021-03-17 EP disclosed
CN-112400018-A Extrahepatic delivery 阿尔尼拉姆医药品有限公司 2021-02-23 CN disclosed
WO-2020257194-A1 DELIVERY OF OLIGONUCLEOTIDES TO THE STRIATUM ALNYLAM PHARMACEUTICALS, INC. (US) 2020-12-24 WO disclosed
WO-2019217459-A1 EXTRAHEPATIC DELIVERY ALNYLAM PHARMACEUTICALS, INC. (US) 2019-11-14 WO disclosed